Search research articles
Contact Us
Filters
Showing results (311-320 of 356) with videos related to
Page
of 36
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 18, 2016
[Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy]
J B Wang, W Jiang, Z Ji, et al.
Nature Communications
|
September 8, 2017
Tunneling anisotropic magnetoresistance driven by magnetic phase transition
X Z Chen, J F Feng, Z C Wang, et al.
Prostate Cancer and Prostatic Diseases
|
November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, S G Zhao, M C Haffner, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
July 21, 2021
[Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy]
C Li, L J Tan, X Liu, et al.
Nature
|
July 24, 2024
A temperate super-Jupiter imaged with JWST in the mid-infrared
E C Matthews, A L Carter, P Pathak, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 25, 2019
[The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma]
W J Ni, W Deng, Z F Xiao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
September 17, 2021
[Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study]
P Zhang, J Zhang, B Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
M Untch, R D Gelber, C Jackisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study
Y K Shi, L Wang, B H Han, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 356) with videos related to
Sort By:
Page
of 36
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 18, 2016
[Technical advancement improves survival in patients with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiotherapy]
J B Wang, W Jiang, Z Ji, et al.
Nature Communications
|
September 8, 2017
Tunneling anisotropic magnetoresistance driven by magnetic phase transition
X Z Chen, J F Feng, Z C Wang, et al.
Prostate Cancer and Prostatic Diseases
|
November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, S G Zhao, M C Haffner, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
July 21, 2021
[Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy]
C Li, L J Tan, X Liu, et al.
Nature
|
July 24, 2024
A temperate super-Jupiter imaged with JWST in the mid-infrared
E C Matthews, A L Carter, P Pathak, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 25, 2019
[The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma]
W J Ni, W Deng, Z F Xiao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
September 17, 2021
[Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study]
P Zhang, J Zhang, B Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 26, 2019
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2008
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
M Untch, R D Gelber, C Jackisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study
Y K Shi, L Wang, B H Han, et al.
Page
of 36